Latest Telomerase Stories
LOS ANGELES, March 17, 2011 /PRNewswire/ -- Genesis Biopharma, Inc. (OTC Bulletin Board: GNBP), a biotechnology company developing targeted cancer therapies, today announced it has appointed William H. Andrews Ph.D. to its Board of Directors. Dr.
Age management leader Cenegenics® Medical Institute announced an added dimension to its highly regarded proactive approach for optimized health, the patented TA-65® Las Vegas, NV (Vocus/PRWEB) March 15, 2011 Cenegenics® Medical Institute, the global age management medicine leader, announced a new addition to its renowned proactive approach to prevent or delay age-related disease for optimized health: telomere science.
High levels of circulating DNA may indicate faster progression of lung cancer and lower overall survival.
NEW YORK, Jan. 13, 2011 /PRNewswire/ -- Telomerase Activation Sciences, Inc. (T.A. Sciences) today announced the issuance of U.S. Patent No. 7,846,904 to the Geron Corporation. The patent covers the use of certain compounds to upregulate telomerase expression in cells. T.A.
For years, scientists have tried to understand why children with Duchenne muscular dystrophy experience severe muscle wasting and eventual death.
RENO, Nev., Nov. 30, 2010 /PRNewswire/ -- On Sunday, a team of scientists at Harvard Medical School led by Dr. Ronald DePinho published research providing strong scientific support for the validity of Sierra Sciences' approach to curing aging.
Harvard scientists believe they might be a step closer to reversing the aging process.
Telomerase is an enzyme that maintains the DNA at the ends of our chromosomes, known as telomeres.
Positive psychological changes that occur during meditation training are associated with greater telomerase activity.
ROYAL PALM BEACH, Fla., Nov. 4, 2010 /PRNewswire/ -- Dr.